Shirkadda MSICS Pharma Oo Helaysa $3.6 Milyan Si Ay U Balaadhiso Tijaabooyinka Dawooyinka Psychedelic-ka Ah
Shirkadda Israa'iil ee Msics Pharma ayaa heshay $3.6 milyan oo doolar si ay u ballaariso tijaabooyinka caafimaad ee daawaynta psilocybin ee loo isticmaalo niyadjabka iyo OCD.